164 related articles for article (PubMed ID: 7219403)
1. Ovarian cancer: current management.
Tyler H; Kardinal CG
Mo Med; 1981 Jan; 78(1):13-6. PubMed ID: 7219403
[No Abstract] [Full Text] [Related]
2. [Comparative study of 2 combined chemotherapy protocols in the treatment of stage III-IV ovarian cancer patients].
Marenich AF; Perevodchikova NI; Grigorova TM; Pashkiavichus RI
Vestn Akad Med Nauk SSSR; 1980; (5):28-32. PubMed ID: 7395336
[No Abstract] [Full Text] [Related]
3. [Views concerning uterine and ovarian sarcomas].
Scarabelli C; Berta V; Confalonieri F; Guarneri A; Marcolli G
Chir Ital; 1978 Dec; 30(6):913-8. PubMed ID: 753547
[No Abstract] [Full Text] [Related]
4. [Initial treatment for ovarian cancer].
Suzuki M; Fujiwara H; Takei Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):224-9. PubMed ID: 19263611
[No Abstract] [Full Text] [Related]
5. [Chemotherapy of ovarian cancers, stage III].
Amiel JL
Nouv Presse Med; 1978 Oct; 7(35):3150-1. PubMed ID: 724482
[No Abstract] [Full Text] [Related]
6. Current management of epithelial carcinoma of the ovary.
Zucker PK; Rosenshein NB
Compr Ther; 1985 May; 11(5):52-9. PubMed ID: 4006423
[No Abstract] [Full Text] [Related]
7. [New developments in the chemotherapy of ovarian cancer (author's transl)].
Brunner KW; Goldhirsch A; Joss R
Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
[No Abstract] [Full Text] [Related]
8. [Polychemotherapy in patients with ovarian cancer].
Kotova DG; Nechaeva ID; Vinokurov VL; Zel'dovich DR; Khasanova DT
Vopr Onkol; 1980; 26(6):7-11. PubMed ID: 7385734
[TBL] [Abstract][Full Text] [Related]
9. Concomitant phase II studies of pyrazofurin and razoxane in alkylating agent-resistant cases of epithelial ovarian carcinoma.
Edmonson JH; Decker DG; Malkasian GD; Webb MJ
Cancer Treat Rep; 1981; 65(11-12):1127-9. PubMed ID: 7296557
[No Abstract] [Full Text] [Related]
10. [Current topic of intraperitoneal infusions for treatment of ovarian cancer].
Fujiwara K
Gan To Kagaku Ryoho; 2008 Feb; 35(2):224-227. PubMed ID: 18372511
[No Abstract] [Full Text] [Related]
11. Ovarian cancer.
Hudson CN
Br J Hosp Med; 1978 Nov; 20(5):568-74. PubMed ID: 216446
[No Abstract] [Full Text] [Related]
12. [Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy].
Bugat R; Guastalla JP; Misset JL
Bull Cancer; 2005 Nov; 92(11):1003-6. PubMed ID: 16316835
[No Abstract] [Full Text] [Related]
13. Therapy of advanced ovarian carcinoma.
N Engl J Med; 1979 Mar; 300(12):676-7. PubMed ID: 763291
[No Abstract] [Full Text] [Related]
14. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
[TBL] [Abstract][Full Text] [Related]
15. Treatment of ovarian teratoma.
Scully RE
Am J Obstet Gynecol; 1979 Sep; 135(1):161-2. PubMed ID: 556190
[No Abstract] [Full Text] [Related]
16. Current status of chemotherapy in gynecologic cancer.
Tropé C; Kristensen G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
[No Abstract] [Full Text] [Related]
17. Recent advances in the management of women with ovarian cancer.
Eltabbakh GH
Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
[TBL] [Abstract][Full Text] [Related]
18. [Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
Serov SF; Irzhanov SI
Vopr Onkol; 1980; 26(3):37-40. PubMed ID: 7368655
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer.
Fujiwara K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():354-8. PubMed ID: 10895180
[No Abstract] [Full Text] [Related]
20. [The silent killer: treatment of a patient by the oncological team].
Lindert AC; Barents JW; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jan; 122(3):65-8. PubMed ID: 622198
[No Abstract] [Full Text] [Related]
[Next] [New Search]
